Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Better be buying, it’l rip again anytime
1.60 on light vol
She is clawing back towards GREEN after $1.91 low for the day
nice day almost $3 $CYAD
WILD RIDE 1.20-.170 nice pop
You predicted it back on 8-1-22. Good catch.
Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial
https://finance.yahoo.com/news/celyad-oncology-announces-fda-lifts-050100149.html
Just In: $CYAD Celyad Oncology Announces November 2020 Investor Conference Schedule
MONT-SAINT-GUIBERT, Belgium, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company...
Read the whole news CYAD - Celyad Oncology Announces November 2020 Investor Conference Schedule
News: $CYAD Celyad Oncology Announces FDA Clearance of IND Application for CYAD-211, First shRNA-based, Non-Gene Edited Allogeneic CAR T Therapy
Phase 1 clinical trial evaluating the off-the-shelf anti-BCMA CAR T candidate CYAD-211 for the treatment of relapsed/refractory multiple myeloma (r/r MM) expected to begin by year-end 2020 CYAD-211 represents the company’s first allogeneic CAR T clinical candidate using shRNA t...
Read the whole news CYAD - Celyad Oncology Announces FDA Clearance of IND Application for CYAD-211, First shRNA-based, Non-Gene Edited Allogeneic CAR T Therapy
News: $CYAD Celyad Announces Board of Directors Evolution with New Appointment
Dr. Christian Homsy steps down from the Celyad Board of Directors as current CEO Filippo Petti is nominated into the role MONT-SAINT-GUIBERT, Belgium, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company f...
In case you are interested CYAD - Celyad Announces Board of Directors Evolution with New Appointment
News: $CYAD Celyad Receives Euro8.5 Million in Grants and Non-Dilutive Funding by the Walloon Region
Funding will support the advancement of the Company’s autologous and allogeneic CAR-T cell therapy programs MONT-SAINT-GUIBERT, Belgium, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical com...
Find out more CYAD - Celyad Receives Euro8.5 Million in Grants and Non-Dilutive Funding by the Walloon Region
News: $CYAD Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights
MONT-SAINT-GUIBERT, Belgium, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced an update on its operational developments for the third quart...
Read the whole news CYAD - Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights
News: $CYAD Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process
MONT-SAINT-GUIBERT, Belgium, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced the successful administration of CYAD-01 produced with...
Got this from CYAD - Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process
Looks like the data was okay, but not great.
News: $CYAD Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
Preliminary interim results from the alloSHRINK Phase 1 trial demonstrate no evidence of GvHD for first-in-class, non-gene edited allogeneic NKG2D-based CAR-T candidate CYAD-101 when administered concurrently with FOLFOX chemotherapy for the treatment of metastatic colorectal cancer (mCRC...
Read the whole news Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors
Phase 1 data to be presented on July 5th at ESMO.
There colorectal cancer drug.
When is a good time to get in on this stock?
I sold to lock in profit since too many RED arrows today. May re-enter next week.
No, I'm not selling. I like the 2,253,469 float now. Actually this R/S is beginning to grow on Me and I'm liking it more and more. As a matter of fact I just increased my ASK.
skeptic0, shouldn't you sell for a profit then? EOM
CYAD old new RHOI had a good day today. The price is now actually higher than it was before the Reverse Split. I'm actually up on this stock now and still holding. What I like now is that the float is so much smaller.
Just a quess but I say probably not. I don't know who Melland is or his connection. We'll see how the Rhino business plays out. I like it better than the Xboard, forget about that.
The Rhino ATV has a motor and can actually go into production and be sold, the Xboard can't. They paid a lot for Rhino however.
No, I'm not defending it at all. It's B.S., they didn't have it in the DEF14 and the Planned Sale(s) in July and Aug stinks. Does these guys have any left?
1-Aug-06 MELLAND, RICHARD
1,000,000 Direct Planned Sale $8,500
20-Jul-06 TATUM, WALT
Director 1,800,000 Direct Planned Sale $25,000
OK We'll see how RHOI does when the dust settles, as long as you are not defending the reverse split and how it came about.
Even for what? You already know what's transpired. It's still being worked through the system. The DTC will likely not be done for a wk. 3 days for US accounts, then Canada, then offshore. Until then this is not a real showing.
I owed you that - now we are even. Thank you for responding.
If you want to offer your opinion as to what transpired with CyberAds, Walt Tatum , the name change and the reverse split that must have broadsided many - let's talk. Otherwise GLTY.
Where the pumps. Just your bashing to get cheap shares.
Most cannot even sell till next week. The DTC needs to do their thing. So tell me where are the Pumps. They aren't working yet.
They are still pumping this POS after the rape of shareholders that just occured. Unbelievable - must live under a rock.
I wonder if Walt Tatum knew about the upcoming split when he cashed in 1.8 million shares to pay himself?
So, I guess this won't trade now for a few days. The DTC takes 3 day usually to complete. What do others think? There is 0 volume today.
No. I went back and reviewed the DEF14 again. NO mention of voting on a R/S.
I tried to call their IR twice. No, I know why they would not return my call and answer my questions. I thought they needed to declare a vote on this first?.. Quiet Period
I predict CYAD will open @ .90-.95 tomorrow;
What it closes at after the surprise 100:1 Reverse Split and name change to RHOI is anyone's guess;
http://otcbb.com/asp/dailylist_detail.asp?d=08/29/2006&mkt_ctg=OTCBB
Good luck.
Where did I predict .10 ? You are full of CRAP
I really do not understand the point that you are trying to make. It is not a buy & hold stock, hasn't been going back the few years that I have followed & traded it and I don't think that it is now. If you think that it is, I am LMAOAY and your prediction of .10. Check back in a month or two and we will see who was right. GL
EZ is the master-he makes $ even on r/s-somehow he knew lol
out for a small loss
It wasn't mentioned in the Def 14C was it? How convenient!!! eom
wow, dodged that bullet.
13:28 08/30/2006 CYAD CyberAds, Inc. Common Stock RHOI Rhino Outdoor International, Inc. Common Stock 1-100 R/S **
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
146
|
Created
|
03/15/05
|
Type
|
Free
|
Moderators |
Posts Today
|
0
|
Posts (Total)
|
146
|
Posters
|
|
Moderators
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |